Penn Pharma Celebrates 4 Years Accident Free
Pharmaceutical manufacturer Penn Pharma, a PCI company, has reached another significant safety milestone this month having operated for four years without a single accident at its facility in Tredegar, South Wales.
This landmark equates to 2.4 million working hours worked by approximately 300 staff and is a record that Penn, now a PCI company, is extremely proud of. Backed by a recent ISO14001 re-certification, the company places equal emphasis on its environmental management system and compliance.
To achieve this record in a standard day-to-day operational environment would be remarkable; however it is even more significant given the substantial expansion programmes undertaken at the site in the last 4 years. First, there was the design and build of the new contained manufacturing facility for the development and manufacturing of highly potent compounds which completed in September 2013, followed by a further capacity expansion resulting in a new large-scale commercial manufacturing suite which became operational in June 2014. Both expansion programmes were completed in less than 12 months, but not at the expense of safety.
To undertake such significant construction programmes while maintaining operational functionality elsewhere in the site and still remain accident free is a truly remarkable achievement and one of which the company and its employees are extremely proud.
Commenting on this latest milestone, Mark Dean-Netscher Vice President, International Operations said: “This type of achievement in safety does not just happen; we have created a safety focused culture by developing robust processes including a very effective ’near miss’ system. When we talk about safety within the business, there is a real sense of pride evident and it is the commitment of our staff which has led to this incredible achievement.”
Mark continued: “Customers can be confident that with this industry benchmark, Penn is uniquely placed as an outsourcing partner. We offer a guaranteed ‘safe pair of hands’ in the extended supply chain.”
This latest announcement is just one of a long list of achievements enjoyed by Penn in recent months; in 2014 Penn won the Facility Integration category at the ISPE Facility of the Year for its new contained manufacturing facility, as well as being awarded three CMO Leadership Awards.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance